Migraine is one of the most common neurological disorders, and for decades it has been debated whether migraine with aura (MwA) and migraine without aura (MwoA) are merely different manifestations of the same disease or whether they are two distinct entities. A recent narrative review in the Journal of Headache and Pain summarizes the available data on epidemiology, genetics, clinical characteristics, neuroimaging and treatment response. The result: there is increasing evidence that the two subtypes differ not only in terms of symptoms, but also in their biological basis. For neurologists, this raises the question of whether understanding these differences should also have diagnostic and therapeutic consequences in the future.
You May Also Like
- Psoriasis: intervening in the inflammatory cascade
Advantages of early biologic therapy and oral peptide as a beacon of hope
- AI-supported imaging and new biomarkers
CHD diagnostics update
- Bipolar disorder, anxiety disorder, depression
Lurasidone as monotherapy for bipolar I depression with anxiety symptoms
- Arterial hypertension: ESC guideline 2024 in focus
New category “elevated blood pressure” – what are the therapeutic implications?
- Low-grade pediatric gliomas
Consideration of the tumor microenvironment opens up new treatment options
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Patient-centered rounds in medicine
Aligning care with the patient
- HIV: antiretroviral therapy (ART)